This is a preview of subscription content, log in via an institution to check access.
References
Angiolini E., Fowden A., Coan P., Sandovici I., Smith P., Dean W. et al. 2006 Regulation of placental efficiency for nutrient transport by imprinted genes. Placenta 27, 99–102.
Apostolidou S., Abu-Amero S., O’Donoghue K., Frost J., Olafsdottir O., Chavele K.M. et al. 2007 Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J. Mol. Med. 85, 379–387.
Constâancia M., Hemberger M., Hughes J., Dean W., Ferguson-Smith A., Fundele R. et al. 2002 Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417, 945–948.
Constância M., Kelsey G. and Reik W. 2004 Resourceful imprinting. Nature 432, 53–57.
Cunningham F. G., Noman F. Gant, Kenneth J. Leveno, Larry C. Gilstrap, John C. Hauth, Katharine D. Westrom et al. 2002 Williams obstetrics, 21st edition. McGraw-Hill, New York, USA.
Feng W., Marquez R. T., Lu Z., Liu J., Lu K. H., Issa J. P. et al. 2008 Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer 112, 1489–1502.
Isles A. R. and Holland A. J. 2005 Imprinted genes and mother-offspring interactions. Early Hum. Dev. 81, 73–77.
Kosaki K., Kosaki R., Craigen W. J. and Matsuo N. 2000 Isoformspecific imprinting of the human PEG1/MEST gene. Am. J. Hum. Genet. 66, 309–312.
Lefebvre L., Viville S., Barton S. C., Ishino F., Keverne E. B. and Surani M. A. 1998 Abnormal maternal behaviour and growth retardation associated with loss of the imprinted geneMest. Nat. Genet. 20, 163–169.
Monk D., Arnaud P., Apostolidou S., Hills F. A., Kelsey G., Stanier P. et al. 2006 Limited evolutionary conservation of imprinting in the human placenta. Proc. Natl. Acad. Sci. USA 103, 6623–6628.
Murrell A., Heeson S., Cooper W. N., Douglas E., Apostolidou S., Moore G. E. et al. 2004 An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum. Mol. Genet. 13, 247–255.
Miles H. L., Hofman P. L. and Cutfield W. S. 2005 Fetal origins of adult disease: a paediatric perspective. Rev. Endocrinol. Metab. Disord. 6, 261–268.
Miozzo M. and Simoni G. 2002 The role of imprinted genes in fetal growth. Biol. Neonate 81, 217–228.
McMinn J., Wei M., Schupf N., Cusmai J., Johnson E. B. and Smith A. C. 2006 Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 27, 540–549.
Ong K. K. and Dunger D. B. 2002 Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults. Best Pract. Res. Clin. Endocrinol. Metab. 16, 191–207.
Onyango P., Miller W., Lehoczky J., Leung C. T., Birren B., Wheelan S. et al. 2000 Sequence and comparative analysis of the mouse 1-megabase region orthologous to human 11p15 imprinted domain. Genome Res. 10, 1697–1710.
Sibley C. P., Coan P. M., Ferguson-Smith A. C., Dean W., Hughes J., Smith P. et al. 2004 Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc. Natl. Acad. Sci. USA 101, 8204–8208.
Smith R. J., Dean W., Konfortova G. and Kelsey G. 2003 Identification of novel imprinted genes in a genome-wide screen for maternal methylation. Genome Res. 13, 558–569.
Zhang Y. and Tycko B. 1992 Monoallelic expression of the human H19 gene. Nat Genet. 1, 40–44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, Y., Fu, J.L., Song, W.W. et al. Genomic imprinting status of IGF-II and H19 in placentas of fetal growth restriction patients. J Genet 89, 213–216 (2010). https://doi.org/10.1007/s12041-010-0027-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-010-0027-9